Drawing for SECURACELL

USPTO serial 99780586

SECURACELL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DANG, PETER T
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with SECURACELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

REBECCA LIEBOWITZ

REBECCA LIEBOWITZ VENABLE LLPP.O. Box 34385Washington, DC 20043United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological reagents for research, scientific and medical laboratory research use; chemical and biological diagnostic reagents for research, scientific, clinical and medical laboratory research use; cell culture media for research, scientific, diagnostic research, and laboratory research use; diagnostic preparations in the nature of diagnostic substances for research and scientific useACTIVE—
005Reagent red blood cells for quality control in immunohematology tests for clinical medical use; diagnostic reagent red blood cells for quality control in immunohematology tests for medical purposes; chemical reagents for clinical medical use; chemical diagnostic reagents for medical purposes; cell culture media and reagents for clinical medical use; diagnostic preparations for clinical medical use; reagent red blood cell and diagnostic preparations for clinical medical use; diagnostic preparations and substances for medical purposes, namely, for clinical, diagnostic, and medical laboratory useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 28, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 28, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 28, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 28, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 28, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2026DOCKASSIGNED TO EXAMINER—
Jul 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 22, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance